Market analysis requires careful attention to the following: Food and Beverage and Agriculture Industries.Petrochemical Refineries & Oil and Gas Industry.Molecular Diagnostics (MDx) & Clinical Research Laboratories.

Contract Services Organizations (CROs and CMOs).

Pharmaceutical and Biotechnology Companies.

Electronic Data Capture (EDC) & Clinical Data Management Systems (CDMS).

Scientific Data Management Systems (SDMS).

Laboratory Information Management Systems (LIMS).

Key Segments Studied in the Global Lab Informatics Market The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027. Players, stakeholders, and other participants in the global Lab Informatics market will be able to gain the upper hand as they use the report as a powerful resource. The research study provides market overview, Lab Informatics market definition, regional market opportunity, sales and revenue by region, manufacturing cost analysis, Industrial Chain, market effect factors analysis, Lab Informatics market size forecast, market data & Graphs and Statistics, Tables, Bar &Pie Charts, and many more for business intelligence.ĭownload Free Sample Copy of ‘ Lab Informatics market’ Report Informatics market is segmented by company, region (country), by Type, and by Application. The transaction is expected to be neutral to Abbott earnings per share in 2007, excluding specified items, and accretive thereafter.The ‘ Lab Informatics market’ research report added by Report Ocean, is an in-depth analysis of the latest developments, market size, status, upcoming technologies, industry drivers, challenges, regulatory policies, with key company profiles and strategies of players. The sale of Abbott's core laboratory diagnostics business to GE is expected to close in the first half of 2007 and is subject to customary closing conditions, including regulatory approvals. 'As part of GE, Abbott's core diagnostics and point-of-care businesses will be powerfully positioned to sustain and extend their market success.' White, chairman and chief executive officer, Abbott. Innovation in this segment will be increasingly driven by automation, system integration and a host of skills that GE can offer,' said Miles D. 'The laboratory diagnostics market has changed considerably in the last decade. Abbott has announced that it will sell its core laboratory diagnostics business included in the Abbott Diagnostics Division and Abbott Point of Care to GE heathcare for $8.13 billion in cash, resulting in approximately $6 billion in after-tax proceeds.Ībbott's Molecular Diagnostics and Diabetes Care businesses are not part of the transaction and will remain part of Abbott.

Abbott core lab